Anthropic Launches Claude Duet — A Proactive AI That Works While You Sleep

by Geth Author

Anthropic Launches Claude Duet — A Proactive AI That Works While You Sleep

Most AI assistants sit idle until you type something. Claude Duet, which Anthropic opened to a research preview on October 21, 2026, flips that relationship: instead of waiting for your questions, it watches your connected apps and comes to you.

Built on Opus 5.5, Claude Duet monitors email, calendars, and Slack in the background, surfaces items that need your attention, and can complete tasks you delegate — even after you've closed your laptop. According to 9to5Mac, the agent runs on its own virtual machine, so your devices don't need to stay powered on for work to happen.

The design philosophy is cautious. Claude Duet is configured to ask before it sends an email, makes a payment, signs anything, or deletes a file. Engadget notes that Anthropic openly acknowledges the agent can still misjudge what's urgent — an honest caveat for a system that's supposed to prioritize on your behalf.

Access is limited for now: US users on Pro and Max plans can join a waitlist. There's no added cost — background activity draws from your existing plan's usage limits. Team and Enterprise tiers aren't included in this first wave.

The timing is pointed. Claude Duet enters a field already occupied by Meta's Muse and OpenAI's Dots, two similar proactive agent products that launched earlier this year. Each is betting that the next frontier in AI isn't smarter answers — it's an agent that already knows what you need.

What distinguishes Claude Duet from raw automation is the human-in-the-loop design. You're not handing over control; you're adding an attentive layer that flags, prepares, and acts only after you greenlight the consequential steps. Whether that balance holds up under real workloads — and whether users actually trust a background agent with their inboxes — is something this preview is designed to find out.

If you're on a qualifying plan and in the US, the waitlist is open now. Expect rough edges — this is explicitly a research preview, not a polished product launch.